GITNUX MARKETDATA REPORT 2024

Psoriasis Industry Statistics

The global psoriasis industry is expected to reach a market value of $21.1 billion by 2026, driven by increasing prevalence of the condition and advancements in treatment options.

With sources from: ncbi.nlm.nih.gov, marketsandmarkets.com, who.int, fortunebusinessinsights.com and many more

Statistic 1

Approximately 125 million people worldwide—2 to 3 percent of the total population—have psoriasis, according to current studies.

Statistic 2

Studies have shown individuals with psoriasis can have a decreased quality of life similar to those with diseases such as cancer and heart disease.

Statistic 3

The global psoriasis treatment market was valued at USD 7.00 billion in 2015 and is expected to reach a value of USD 10.68 by 2022.

Statistic 4

Psoriasis drugs market in the United States is projected reach USD 13.3 billion by 2025.

Statistic 5

The prevalence of Psoriasis in the United States is approximately 7.5 million.

Statistic 6

From 2020 to 2025, the psoriasis therapeutics market is expected to grow at a 7.3% CAGR.

Statistic 7

North America is projected to account for the largest share of the global psoriasis therapeutics market in 2020.

Statistic 8

Approximately 3% of the world population has some form of psoriasis.

Statistic 9

Up to 30% of people with psoriasis will eventually develop psoriatic arthritis.

Statistic 10

Among those living with psoriasis, about 80% have moderate to severe disease.

Statistic 11

An estimated 20% of psoriasis cases among adults were moderate to severe as of 2005.

Statistic 12

The psoriasis drug industry is predicted to rise at a CAGR of 9.79% between 2021 and 2026.

Statistic 13

Adults with severe psoriasis can die on average 3 to 5 years earlier than those without the disease.

Statistic 14

Psoriasis often appears between the ages of 15 and 25, but can develop at any age.

Statistic 15

Studies show that between 10 and 30 percent of people with psoriasis also develop psoriatic arthritis.

Statistic 16

Europe is expected to account for the second-largest share in the psoriasis therapeutics market.

Statistic 17

According to the World Health Organization, nearly 60% of psoriasis sufferers report their disease to be a large problem in their everyday life.

Statistic 18

By 2027, the global psoriasis drugs market is predicted to reach USD 24.1 billion.

Statistic 19

Plaque psoriasis is the most common form of psoriasis, accounting for about 90% of reported cases.

Statistic 20

Approximately 1 in 3 people with psoriasis report having a relative with the disease.

Sources Icon Sources

In this post, we will explore the significant impact of psoriasis on a global scale and delve into the key statistics driving the psoriasis industry. With approximately 125 million individuals affected worldwide, the market for psoriasis treatments is poised for substantial growth in the coming years. We will examine the latest data on prevalence rates, market values, and the challenges faced by those living with this chronic skin condition.

Statistic 1

"Approximately 125 million people worldwide—2 to 3 percent of the total population—have psoriasis, according to current studies."

Sources Icon

Statistic 2

"Studies have shown individuals with psoriasis can have a decreased quality of life similar to those with diseases such as cancer and heart disease."

Sources Icon

Statistic 3

"The global psoriasis treatment market was valued at USD 7.00 billion in 2015 and is expected to reach a value of USD 10.68 by 2022."

Sources Icon

Statistic 4

"Psoriasis drugs market in the United States is projected reach USD 13.3 billion by 2025."

Sources Icon

Statistic 5

"The prevalence of Psoriasis in the United States is approximately 7.5 million."

Sources Icon

Statistic 6

"From 2020 to 2025, the psoriasis therapeutics market is expected to grow at a 7.3% CAGR."

Sources Icon

Statistic 7

"North America is projected to account for the largest share of the global psoriasis therapeutics market in 2020."

Sources Icon

Statistic 8

"Approximately 3% of the world population has some form of psoriasis."

Sources Icon

Statistic 9

"Up to 30% of people with psoriasis will eventually develop psoriatic arthritis."

Sources Icon

Statistic 10

"Among those living with psoriasis, about 80% have moderate to severe disease."

Sources Icon

Statistic 11

"An estimated 20% of psoriasis cases among adults were moderate to severe as of 2005."

Sources Icon

Statistic 12

"The psoriasis drug industry is predicted to rise at a CAGR of 9.79% between 2021 and 2026."

Sources Icon

Statistic 13

"Adults with severe psoriasis can die on average 3 to 5 years earlier than those without the disease."

Sources Icon

Statistic 14

"Psoriasis often appears between the ages of 15 and 25, but can develop at any age."

Sources Icon

Statistic 15

"Studies show that between 10 and 30 percent of people with psoriasis also develop psoriatic arthritis."

Sources Icon

Statistic 16

"Europe is expected to account for the second-largest share in the psoriasis therapeutics market."

Sources Icon

Statistic 17

"According to the World Health Organization, nearly 60% of psoriasis sufferers report their disease to be a large problem in their everyday life."

Sources Icon

Statistic 18

"By 2027, the global psoriasis drugs market is predicted to reach USD 24.1 billion."

Sources Icon

Statistic 19

"Plaque psoriasis is the most common form of psoriasis, accounting for about 90% of reported cases."

Sources Icon

Statistic 20

"Approximately 1 in 3 people with psoriasis report having a relative with the disease."

Sources Icon

Interpretation

In conclusion, psoriasis is a widespread and burdensome condition affecting millions of individuals globally. The statistics presented highlight the significant impact of psoriasis on both societal health and economies, with projections showing substantial growth in the psoriasis treatment market. The data also emphasize the importance of continued research and development in the field to address not only the physical manifestations of the disease but also its adverse effects on individuals' quality of life. Furthermore, the high prevalence of psoriatic arthritis among psoriasis patients and the increased mortality risk associated with severe cases underscore the urgent need for effective and accessible treatment options.

Can You Trust Our Report?

The statistics are checked by us and then entered into the database. Our market data reports have been linked to by some of the largest publishers and companies on the Internet.

Learn more about our process here.

Submit Your Own Statistic Data

Would you like to submit your own researched statistics on this topic? You are welcome to use the form below and submit your suggestion to us. We will check the source and approve it if necessary.

... Before You Leave, Catch This! 🔥

Your next business insight is just a subscription away. Our newsletter The Week in Data delivers the freshest statistics and trends directly to you. Stay informed, stay ahead—subscribe now.

Sign up for our newsletter and become the navigator of tomorrow's trends. Equip your strategy with unparalleled insights!